Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF)
Total Costs & Expenses
$10.14M
TTM · Period ending: · USD
CANF Total Costs & Expenses
Latest reported$10.14Mperiod ending
Latest reported$10.14Mperiod ending
CANF TTM Total Costs & Expenses ($5.49M → $10.14M)
TTM Total Costs & Expenses
High-resolution chart · PNG
CANF total costs & expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 10,137,000 | |
| 10,246,000 | |
| 10,355,000 | |
| 9,924,499 | |
| 9,493,998 | |
| 9,148,998 | |
| 8,803,998 | |
| 8,595,999 | |
| 8,460,000 | |
| 8,235,000 | |
| 8,938,000 | |
| 10,229,000 | |
| 10,945,000 | |
| 11,239,000 | |
| 10,906,000 | |
| 11,858,000 | |
| 12,842,000 | |
| 13,951,000 | |
| 13,695,000 | |
| 13,166,000 | |
| 12,095,000 | |
| 12,747,000 | |
| 14,902,000 | |
| 15,998,000 | |
| 17,251,000 | |
| 16,499,000 | |
| 14,035,000 | |
| 12,028,000 | |
| 10,070,000 | |
| 9,024,000 | |
| 9,234,000 | |
| 8,945,251 | |
| 8,714,976 | |
| 8,424,343 | |
| 8,220,449 | |
| 8,307,412 | |
| 8,885,065 | |
| 9,115,756 | |
| 8,803,356 | |
| 8,625,773 | |
| 7,703,403 | |
| 7,069,312 | |
| 6,579,721 | |
| 5,826,748 | |
| 5,793,355 | |
| 6,413,474 | |
| 7,132,381 | |
| 8,917,424 | |
| 9,092,382 | |
| 9,111,289 | |
| 8,900,932 | |
| 7,544,407 | |
| 7,194,401 | |
| 6,254,380 | |
| 6,110,513 | |
| 5,316,248 | |
| 5,283,247 | |
| 5,434,694 | |
| 5,493,526 | |
| 5,473,127 | |
| 5,306,746 |